Diabetes drug tested to shield ICU patients from kidney failure
Prevention
Terminated
This study tested whether dapagliflozin, a drug used for diabetes and chronic kidney disease, could prevent acute kidney injury in critically ill patients in the intensive care unit. The trial aimed to enroll 3000 adults but was terminated early after only 51 participants. Partic…
Phase: PHASE3 • Sponsor: The George Institute • Aim: Prevention
Last updated May 11, 2026 20:50 UTC